Article Text

This article has a correction. Please see:

other Versions

PDF
Baseline and one year Magnetic Resonance Imaging of the sacroiliac joint and lumbar spine in very early inflammatory back pain. The relationship between symptoms, HLA-B27, and disease extent and persistence.
  1. Helena Marzo-Ortega (medhmo{at}leeds.ac.uk)
  1. Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom
    1. Dennis McGonagle (meddgm{at}leeds.ac.uk)
    1. Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom
      1. Philip O'Connor (philip.o'connor{at}leedsth.nhs.uk)
      1. Department of Musculoskeletal Radiology, Chapel Allerton Hospital, United Kingdom
        1. Elizabeth MA Hensor (e.m.a.hensor{at}leeds.ac.uk)
        1. Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom
          1. Alexander N Bennett (alexander.n.bennett{at}btinternet.com)
          1. Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom
            1. Michael J Green (drmjgreen{at}doctors.org.uk)
            1. Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom
              1. Paul Emery (p.emery{at}leeds.ac.uk)
              1. Leeds Institute of Molecular Medicine, University of Leeds, United Kingdom

                Abstract

                Objectives: The precise anatomical location of pathology associated with inflammatory back pain (IBP) in early SpA remains unclear. We used MRI to study the SIJ and lumbar spine (LS) and explored the relationship between sites and extent of inflammation and HLA-B27 status over 12 months.

                Methods: 54 IBP patients; median duration 24 weeks (54% HLA-B27 positive; median BASDAI 5.65) and 22 control subjects (n=11 mechanical back pain; n= 11 volunteers) were recruited and 63% (n=34) were re-assessed at 1 year. Fat saturation and T1W MRI was performed with images being scored for active bone marrow oedema (BMO) lesions representative of inflammation.

                Results: At baseline 85% of the patients had BMO (SIJs and LS) vs 40% in the control group. The majority of affected patients had inflammation at the SIJ level (95 % [n=44]; 23.5% [n=12] LS) and 28.2% (n=13) at both sites simultaneously. The SIJ activity score confirmed more severe inflammation (BMO grade 2 or 3: 52.2%) in the IBP group (controls= BMO grade 1: 100%; p<0.001). HLA-B27 was associated with both the severity (p=0.009) and number of baseline SIJ lesions (p=0.045) and with persistence (SIJ or LS) at one year (p=0.02). 90% of re-attenders fulfilled ESSG criteria; 73.5% showed MRI inflammation despite clinical improvement (median BASDAI 5.65 to 3.05; p<0.009).

                Conclusion: LS and SIJ involvement may occur simultaneously in very early SpA and may be differentiated from non-inflammatory back pain on the severity of MRI lesions. HLA-B27 is associated with both the severity of osteitis and its persistence.

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

                Linked Articles

                • Miscellaneous
                  BMJ Publishing Group Ltd and European League Against Rheumatism